Oligodendroglial tau filament formation in transgenic mice expressing G272V tau

European Journal of Neuroscience

Volumn 13, Issue 11, 2001, Pages 2131-2140

  Götz, Jürgen ^a   Tolnay, Markus ^b   Barmettler, Robi ^a   Chen, Feng ^a   Probst, Alphonse ^b   Nitsch, Roger M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; Frontotemporal dementia; Phosphorylation; Transactivator

Indexed keywords

DIRECT YELLOW 7; EPITOPE; GOLD; MUTANT PROTEIN; PRION PROTEIN; TAU PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; FRONTOTEMPORAL DEMENTIA; IMMUNOGOLD STAINING; IN VIVO STUDY; MOTOR NEURON DISEASE; MOUSE; NEUROFILAMENT; NONHUMAN; OLIGODENDROGLIA; PARKINSONISM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPINAL CORD; TRANSGENIC MOUSE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOSKELETON; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MUTATION; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; NEURONS; OLIGODENDROGLIA; PHOSPHORYLATION; SOLUBILITY; TAU PROTEINS; TETRACYCLINE; TRANS-ACTIVATORS;

EID: 0034948975     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01604.x     Document Type: Article

References (46)

1. Orientation, assembly, and stability of microtubule bundles induced by a fragment of tau protein
2. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
3. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
4. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease
5. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
6. Multiple system atrophy: A sporadic synucleinopathy
7. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
8. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
9. The tauopathies: Toward an experimental animal model
10. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
11. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
12. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
13. Molecular dissection of the paired helical filament
14. Tau and transgenic animal models
15. Tau filament formation in transgenic mice expressing P301L tau
16. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha
17. Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development
18. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
19. 5′ Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
20. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation
21. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
22. Glial tau pathology in neurodegenerative diseases: Their nature and comparison with neuronal tangles
23. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
24. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
25. The definition of multiple system atrophy: A review of recent developments
26. Neurodegenerative tauopathies: Human disease and transgenic mouse models
27. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
28. Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction
29. Tau is a candidate gene for chromosome 17 frontotemporal dementia
30. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
31. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (pallido-ponto-nigral degeneration)
32. Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons
33. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice
34. Tau protein pathology in neurodegenerative diseases
35. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
36. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
37. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
38. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
39. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex
40. REVIEW: Tau protein pathology in Alzheimer's disease and related disorders
41. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles
42. Transgenic models of tauopathies and synucleinopathies
43. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
44. Calpain and caspase: Can you tell the difference?
45. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles
46. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion